GSK Failed to Warn Expectant Mothers that Anti-Nausea Drug Zofran Causes Birth Defects, Lawsuit Says

BOSTON — A Massachusetts woman has sued GlaxoSmithKline, alleging the drug maker off-label marketed its anti-nausea drug Zofran as a morning sickness remedy while concealing its knowledge that ingestion of the drug by pregnant women can cause serious birth defects.

In a Feb. 13 complaint filed in the U.S. District Court for the District of Massachusetts, the plaintiff alleged that her ingestion of Zofran caused her daughter to be born with multiple birth defects and that GSK failed to warn her and her physician of this risk.

Tomisha LeClair said that her minor child, A.S., was born in 2000 with …